{
  "id": "606bfca094d57fd879000072",
  "type": "summary",
  "question": "What is the Oncomine Dx Target test?",
  "ideal_answer": "The Oncomine Dx Target Test (ODxTT) is a next-generation sequencing-based companion diagnostic test, that could facilitate access to multiple biomarker testing using small tissue samples to support therapy decisions for patients with advanced NSCLC.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/30243889",
    "http://www.ncbi.nlm.nih.gov/pubmed/33185331"
  ],
  "snippets": [
    {
      "text": "The Oncomine Dx Target Test (ODxTT) is a next-generation sequencing-based companion diagnostic test which has been recently developed; however, its analysis success rate could be improved, especially for small samples.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33185331",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Preliminary assessment of the investigational Oncomine Dx Target Test suggests it could facilitate access to multiple biomarker testing using small tissue samples to support therapy decisions for patients with advanced NSCLC.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30243889",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}